Lenz Therapeutics Inc (LENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,127 | -46,231 | -29,531 | -14,619 | -49,769 |
| Depreciation Amortization | 287 | 180 | -1,967 | -1,098 | 58 |
| Accounts receivable | -329 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -90 | 66 | -1,628 | -771 | -4,279 |
| Other Working Capital | 3,253 | 3,756 | -1,541 | -2,969 | -11,755 |
| Other Operating Activity | 9,836 | 6,084 | 7,110 | 3,408 | 6,354 |
| Operating Cash Flow | $-69,170 | $-36,145 | $-27,557 | $-16,049 | $-59,391 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -827 | -789 | -350 | -110 | -468 |
| Purchase Of Investment | -280,803 | -147,691 | -91,385 | -33,091 | -241,911 |
| Sale Of Investment | 205,962 | 162,622 | 110,210 | 52,090 | 87,900 |
| Investing Cash Flow | $-75,668 | $14,142 | $18,475 | $18,889 | $-154,479 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,996 | 27,130 | 26,532 | 44 | 83,551 |
| Other Financing Activity | 147,749 | 0 | 0 | 0 | 115,451 |
| Financing Cash Flow | $149,745 | $27,130 | $26,532 | $44 | $199,002 |
| Beginning Cash Position | 20,272 | 20,272 | 20,272 | 20,272 | 35,140 |
| End Cash Position | 25,179 | 25,399 | 37,722 | 23,156 | 20,272 |
| Net Cash Flow | $4,907 | $5,127 | $17,450 | $2,884 | $-14,868 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,170 | -36,145 | -27,557 | -16,049 | -59,391 |
| Capital Expenditure | -827 | -789 | -350 | -110 | -468 |
| Free Cash Flow | -69,997 | -36,934 | -27,907 | -16,159 | -59,859 |